The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October. Read More
reported by at Moneycontrol
The companies said, assuming success of the vaccine in clinical studies, they are on track to seek regulatory review for the vaccine as early as October. Read More
reported by at Moneycontrol
Recent Comments